Exelixis, Inc. (EXEL) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Exelixis, Inc.
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior…
Source: Yahoo Finance
Sector & Industry
Exelixis, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Exelixis, Inc. at a Glance
| Company | Exelixis, Inc. |
| Ticker | EXEL |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $59.01 |
| Market cap | $14.62B |
| P/E ratio (trailing) | 18.56 |
| EPS (trailing) | $3.18 |
| 52-week high | $59.72 |
| 52-week low | $33.76 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.42 |
| Return on equity (ROE) | 44.39% |
| Debt-to-equity | 9.00% |
| Average volume | 2.54M |
| Shares outstanding | 247.78M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 1,077 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Exelixis, Inc.'s current P/E ratio?
- Exelixis, Inc. (EXEL) has a trailing P/E ratio of 18.56 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Exelixis, Inc.'s market capitalisation?
- Exelixis, Inc.'s market cap is $14.62B based on our latest snapshot. See how it ranks by market cap →
- What is EXEL's 52-week range?
- Over the past 52 weeks, EXEL has traded between $33.76 and $59.72. What does the 52-week range mean? →
- How volatile is Exelixis, Inc. compared to the market?
- Exelixis, Inc. has a beta of 0.42, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Exelixis, Inc. pay a dividend?
- Exelixis, Inc. does not currently pay a dividend according to our latest data.
- What exchange is EXEL listed on?
- EXEL is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Exelixis, Inc. in?
- Exelixis, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →